Active Partners led the seed round for the London nursery group, which plans to open new sites and develop its digital offering.
"I became so invested in my search and learning about child development, that I teamed up with experts to help me create this warm, conscious and nurturing environment for kids. I am really proud of what we have achieved so far, but the best is yet to come. We are thrilled to have Active Partners onboard to support us in bringing our unique childcare approach to many more children across London."
The Stockholm-founded investor led the financing to help accelerate commercialisation of the firm's carbon capture technology.
"The foundation, formulation, and chemicals industries are some of the world's greatest polluters and many have aimed to reach carbon neutrality by 2050. ViridiCO2 is focused on assisting the chemicals industry to decarbonise by putting the 7 billion tonnes of industry waste CO2 to good use, creating sustainable products, and a new income source."
The pre-seed round was backed by Antler, Fuel Ventures, ScaleX and Logo Ventures to help drive team growth and new market entry.
"We believe the future of sales is driven by digital experiences that enable buyers. As competition increases, teams are forced to differentiate not only with the service they provide but also with the way they sell. Helping buyers make informed decisions is the new definition of success and sadly, email threads no longer achieve this. This funding will allow us to realise our ambition to build the de facto medium where B2B sales happens."
The Didsbury startup secured its third fundraise from a mix of new and existing angels.
"It’s a really important fundraise for My First Five Years. We’re two years old as a business and 2023 is a critical year for us as we demonstrate market traction and proof that parents are willing to pay for the app."
Oxford Innovation and OION angels have backed Cognitant Group in a follow-on funding round.
"We are focused on making it easier for patients to understand their symptoms and management of their individual condition. This not only has a positive impact on their overall health, but it also allows them to successfully make decisions about their individual treatment plans in collaboration with their clinicians. Our partnerships with global pharmaceutical companies, the NHS and other healthcare providers, is making real and valuable changes to the way patients engage with and manage their health."
.webp)
